PRPO - Precipio Inc Stock Price, Fair Value and News

$24.60+0.04 (+0.16%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

PRPO Price Action

Last 7 days

3.6%

Last 30 days

23.2%

Last 90 days

52.8%

Trailing 12 Months

317.0%

PRPO RSI Chart

PRPO Valuation

Market Cap

43.1M

Price/Earnings (Trailing)

-34.37

Price/Sales (Trailing)

1.9

EV/EBITDA

474.99

Price/Free Cashflow

75.61

PRPO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

PRPO Fundamentals

PRPO Revenue

Revenue (TTM)

22.7M

Rev. Growth (Yr)

28.16%

Rev. Growth (Qtr)

19.69%

PRPO Earnings

Earnings (TTM)

-1.3M

Earnings Growth (Yr)

87.38%

Earnings Growth (Qtr)

-206.76%

PRPO Profitability

EBT Margin

-5.52%

Return on Equity

-9.12%

Return on Assets

-5.93%

Free Cashflow Yield

1.32%

PRPO Investor Care

Shares Dilution (1Y)

18.19%

Diluted EPS (TTM)

-0.82

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	20.0M	21.2M	22.8M	0
2024	16.0M	16.8M	17.5M	18.5M
2023	10.1M	11.3M	13.6M	15.4M
2022	9.1M	9.3M	9.5M	9.8M
2021	6.7M	7.3M	7.4M	8.7M
2020	4.7M	5.1M	6.1M	6.1M
2019	3.6M	3.8M	4.0M	4.1M
2018	2.5M	3.2M	3.7M	3.4M
2017	2.0M	1.7M	1.5M	2.0M
2016	1.4M	1.6M	1.7M	1.9M
2015	19.3M	13.0M	9.2M	1.9M
2014	26.4M	25.9M	23.3M	24.8M
2013	31.6M	29.9M	28.6M	27.5M
2012	31.7M	33.1M	32.8M	31.5M
2011	22.1M	24.7M	28.5M	32.0M
2010	0	0	0	20.0M

Get all data in R, Python etc through our Historical Stock Data APIs

About Precipio Inc

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.

CEO	Mr. Ilan Danieli
WEBSITE	precipiodx.com
SECTOR	Healthcare
INDUSTRY	Diagnostics & Research
EMPLOYEES	53

Precipio Inc Frequently Asked Questions

What is the ticker symbol for Precipio Inc? What does PRPO stand for in stocks?

PRPO is the stock ticker symbol of Precipio Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Precipio Inc (PRPO)?

As of Wed Dec 03 2025, market cap of Precipio Inc is 43.1 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PRPO stock?

You can check PRPO's fair value in chart for subscribers.

Is Precipio Inc a good stock to buy?

The fair value guage provides a quick view whether PRPO is over valued or under valued. Whether Precipio Inc is cheap or expensive depends on the assumptions which impact Precipio Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PRPO.

What is Precipio Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, PRPO's PE ratio (Price to Earnings) is -34.37 and Price to Sales (PS) ratio is 1.9. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PRPO PE ratio will change depending on the future growth rate expectations of investors.